{"id":7009,"date":"2022-07-15T04:53:04","date_gmt":"2022-07-15T04:53:04","guid":{"rendered":"https:\/\/edgebd.ca\/rbc\/?p=7009"},"modified":"2024-03-10T04:55:09","modified_gmt":"2024-03-10T04:55:09","slug":"rwanda-implements-the-accord-for-a-healthier-world-signed-with-pfizer","status":"publish","type":"post","link":"https:\/\/rbc.gov.rw\/beta\/rwanda-implements-the-accord-for-a-healthier-world-signed-with-pfizer\/","title":{"rendered":"Rwanda implements the \u2018Accord for a Healthier World\u2019 signed with Pfizer"},"content":{"rendered":"<p><b>Kigali July 14, 2022<\/b> \u2013 The Ministry of Health initiated implementation of the \u2018Accord for a Healthier World\u2019 signed during World Economic Forum in Davos between the Government of Rwanda and Pfizer, a global pharmaceutical company. The event took place on July 14, 2022 in Kigali.<\/p>\n<p>As per the accord, Pfizer is committed to providing on a not-for-profit basis its patent-protected medicines and vaccines currently marketed in the United States of America or the Eurpean Union to Rwanda in the last 10 years.<\/p>\n<p>The implementation of this accord was marked by a training of <b>100 doctors<\/b><span lang=\"EN-GB\">on Nirmatrelvir\/Ritonavir (Paxlovid) clinical data, indications, usage, and drug-drug interactions<\/span>and on ensuring health equity in Rwanda.<\/p>\n<p>In his remarks, Minister of Health Dr. Daniel Ngamije, said that this training was timely and knowledge from the training will help counter the severity of Covid-19. \u201cWe expect this training will equip you with the necessary knowledge on the efficacy, safety, dosing and drug-drug interactions of this medication, and the appropriate use of Paxlovid will help in the effective and early management of COVID-19 which will reduce the severity.\u201d<\/p>\n<p>Rwanda, which is the first country among 42 nations to sign the agreement that committed to implementing the agreement, received the medicines including that of COVID-19.<\/p>\n<p>Minister Dr. Ngamije said, &#8220;Rwanda is starting to see the first results. We use\u00a0 Paxlovid to treat patients with symptoms of COVID-19, we will use it to treat those with symptoms of COVID-19 and in five days people feel better.&#8221;<\/p>\n<p>Paxlovid is a drug produced by Pfizer and in late 2021, the first drug was released by the United States to fight the COVID-19 virus.<\/p>\n<p>Other engagements with Pfizer in this accord include but are not limited to: the roll out of the use of new COVID-19 antiviral medication Paxlovid, identification of areas for partnership between Rwandan medical specialists in oncology, internal medicine and rare &amp; inflammatory diseases in education, diagnostics, therapeutics, research, and establishment of a telemedicine consultation platform between Rwandan medical doctors and other experts using these drugs worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kigali July 14, 2022 \u2013 The Ministry of Health initiated implementation of the \u2018Accord for a Healthier World\u2019 signed during World Economic Forum in Davos&#8230;<\/p>\n","protected":false},"author":1,"featured_media":7010,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[44],"tags":[],"class_list":{"0":"post-7009","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-press-releases"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/posts\/7009"}],"collection":[{"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/comments?post=7009"}],"version-history":[{"count":1,"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/posts\/7009\/revisions"}],"predecessor-version":[{"id":7011,"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/posts\/7009\/revisions\/7011"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/media\/7010"}],"wp:attachment":[{"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/media?parent=7009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/categories?post=7009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rbc.gov.rw\/beta\/wp-json\/wp\/v2\/tags?post=7009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}